The FDA approved Cytotec, manufactured by Searle, on March 17, 1999. Cytotec is approved to treat ulcers. With the increasing off label usage of Cytotec as a labor-inducing drug, Searle sent physicians a letter in August 2000 reminding them that Cytotec is not approved to induce labor. Cytotec’s sole appeal for inducing labor is price; Cytotec costs pennies per induction.
There are growing concerns about the safety of this drug when used for labor induction. A November 1999 Committee Opinion of the American College of Obstetricians and Gynecologists (ACOG) warns: ″There have been reports of uterine rupture following Cytotec use for cervical ripening in patients with prior uterine surgery. Thus, until reassuring studies are available, Cytotec is not recommended for cervical ripening in patients who have had prior cesarean delivery or major uterine surgery.
Mothers seldom die as a result of ruptures, but babies often do. Obstetricians generally react to a rupture by performing a complete hysterectomy, eliminating all possibility of future biological children. Other risks of Cytotec include increased incidence of jaundice in the baby, fetal distress caused by uterine hyper stimulation, fluid overload from the IV use, increased blood loss post-partum, amniotic fluid embolism, uterine rupture, and an overall increased risk of instrumental or surgical delivery, death and birth defects.
Legal Help For Victims Affected By Cytotec
If you or your baby were adversely affected by Cytotec, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us at 1-800-YOURLAWYER (1-800-968-7529)